Optimizing Oncology Market Research & Analytics

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS

Market research and analytics organizations play a vital role in providing oncology brand teams with the information they need to make better decisions, quicker. In today's complex, rapidly changing oncology marketplace, it is more important than ever that these organizations launch the right activities at the right time with the right level of resources to provide a brand with a competitive edge.

This 40-slide presentation will help pharmaceutical and biotech companies evaluate and improve the effectiveness of their oncology market research and analytics (MR&A) programs.

Industries Profiled:
Pharmaceutical; Biotech; Diagnostic; Chemical; Manufacturing; Consumer Products; Medical Device

Companies Profiled:
Novartis; Genmab; Human Genome Sciences; Eli Lilly and Company; Genentech; Janssen Cilag Pharmaceutical; Ortho Biotech; Daiichi Pharmaceutical Co.; Ltd.; Bayer; Serono

Study Snapshot

This research originated from an original client research for a member of Best Practices, LLC Business Excellence Board (link to site). The research was based on a survey of directors and managers of market research and analytic functions in 11 leading pharmaceutical and biotechnology companieDistribution of MR&A Resources at each Phase of Drug Developments.

Key topics include:

Allocation of MR&A Resources across Functions, including Market research, Market Analytics, Forecasting, Competitive Intelligence, and Strategic Business Planning.
Levels of Market Research Activities by Product Development Phase
Distribution of Market Research Headcount and Budget by Product Development Phase
Budget Allocation Trends by MR&A Function
Level of Outsourcing of Market Research Studies and Projects
Degree of Centralization of Individual MR&A Functions
Market Research FTE’s per Oncology Product
Effective Internal Stakeholder Communication Methods
Key Lessons Learned - Successes and Risks

Key Findings

A large majority of the benchmark class commissions market research within Phase I of product development.

On average, the benchmarked companies allocate 20% of their Market Research & Analytics headcount to pre-Phase III activities.
Outsourcing dominates market research strategy at the benchmarked companies.

Optimizing Oncology Market Research & Analytics

ID: PSM-217

Features:

Pages: 40

Published: Pre-2019

Delivery Format: Shipped

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6EB224316C12A6BD7852571C0004E31CE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/optimizing-oncology-market-research-analytics
18
19
20172.70.100.68
21
22
23527255.sherryhk.tech
24/bestp/domrep.nsf
25BMR